Cargando…

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests

The Centers for Medicare & Medicaid Services (CMS) recommend covering blood-based tests meeting proposed minimum performance thresholds for colorectal cancer (CRC) screening. Outcomes were compared between currently available stool-based screening tests and a hypothetical blood-based test meetin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fendrick, A. Mark, Vahdat, Vahab, Chen, Jing Voon, Lieberman, David, Limburg, Paul J., Ozbay, A. Burak, Kisiel, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457617/ https://www.ncbi.nlm.nih.gov/pubmed/37466476 http://dx.doi.org/10.1089/pop.2023.0037

Ejemplares similares

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model
por: Piscitello, Andrew, et al.
Publicado: (2020)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks
por: Vahdat, Vahab, et al.
Publicado: (2023)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing
por: Barthold, Douglas, et al.
Publicado: (2022)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
por: Fisher, Deborah A., et al.
Publicado: (2021)

Stool-Based Tests for Colorectal Cancer Screening: Performance Benchmarks Lead to High Expected Efficacy
por: Ebner, Derek W., et al.
Publicado: (2020)

Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
por: Yang, Cuiping, et al.
Publicado: (2020)

Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
por: Ansa, Benjamin E., et al.
Publicado: (2021)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening
por: Redwood, Diana G., et al.
Publicado: (2019)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study
por: Itzkowitz, Steven, et al.
Publicado: (2023)

Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)
por: Heigh, Russell I., et al.
Publicado: (2014)

A Practical Overview of the Stool DNA Test for Colorectal Cancer Screening
por: Anand, Sanya, et al.
Publicado: (2022)

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
por: Adler, Andreas, et al.
Publicado: (2014)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults
por: Weiser, Emily, et al.
Publicado: (2020)

Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy
por: Eckmann, Jason D., et al.
Publicado: (2020)

Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening
por: Liu, Po-Hong, et al.
Publicado: (2023)

A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
por: Ze, Yuan, et al.
Publicado: (2023)

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
por: Bosch, L.J.W., et al.
Publicado: (2019)

Systematic Review of Interventions to Increase Stool Blood Colorectal Cancer Screening in African Americans
por: Roy, Siddhartha, et al.
Publicado: (2020)

A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer
por: Ma, Liang, et al.
Publicado: (2022)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries
por: Wu, Grace Hui-Min, et al.
Publicado: (2006)

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019)

Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities
por: Bailey, James R., et al.
Publicado: (2016)

DNA methylation biomarkers in stool for early screening of colorectal cancer
por: Chen, Jie, et al.
Publicado: (2019)

Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models
por: Wieszczy, Paulina, et al.
Publicado: (2021)

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020)

Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
por: Zhu, Yunfeng, et al.
Publicado: (2022)

Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening
por: An, Sung Whan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hs1om5bnj429aun38vui5c1g9s